[1] Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001

[2] Patent omphalo-mesenteric duct associated with Ascaris lumbricoides infestation

[3] Impetigo: etiology and therapy

[4] Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship

[5] Streptococcus pneumoniae skin and soft tissue infections: characterization of causative strains and clinical illness

[6] Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient

[7] The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

[8] Early detection of streptococcal group antigens in skin samples by latex particle agglutination

[9] Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

[10] Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management

[11] Atypical mycobacterial infections of Hickman catheter exit sites

[12] Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin

[13] Anthrax

[14] Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005

[15] Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group

[16] Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections

[17] Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study

[18] Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

[19] Aerobic and anaerobic bacteriology of subcutaneous abscesses

[20] Exacerbation of skin mycobacterial lesions under highly active antiretroviral therapy in an HIV-infected patient

[21] An outbreak of staphylococcal skin infections among river rafting guides

[22] Epidemiology of Skin Diseases among Displaced People in Diyala Province

[23] The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers

[24] Profile of skin diseases in a community of fishermen in the northern coast of the state of São Paulo: the expected and the unusual.

[25] Profile of skin diseases in a community of fishermen in the northern coast of the state of São Paulo: The expected and the unusual

[26] Occupational skin diseases and prevention among sanitation workers in China.

[27] Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases

[28] Antimicrobial Activity, Antioxidant Potential, Cytotoxicity and Phytochemical Profiling of Four Plants Locally Used against Skin Diseases.

[29] screening for skin diseases among primary school children in a rural area of puducherry

[30] interferon gamma gene polymorphism as a marker of some allergic diseases (allergic skin diseases and allergic conjunctivitis) in a sample of egyptian population

[31] the role of antimicrobial peptides in chronic inflammatory skin diseases

[32] cutaneous leishmaniasis in suspected patients referred to the center for research and training in skin diseases and leprosy, tehran, iran from 2008 to 2011

[33] assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases avaliação da qualidade de vida em pacientes pediátricos com as principais dermatoses crônicas da infância

[34] the role of toll-like receptors in skin diseases

[35] Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases.

[36] Current State of SLC and ABC Transporters in the Skin and Their Relation to Sweat Metabolites and Skin Diseases

[37] Financing care for Severe Stigmatizing Skin Diseases (SSSDs) in Liberia: challenges and opportunities

[38] Barriers and Enablers to Health-Seeking for People Affected by Severe Stigmatising Skin Diseases (SSSDs): A Scoping Review